6660 — AIM Vaccine Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Annual cashflow statement for AIM Vaccine Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	486	-607	-434	-2,271	-291
Depreciation
Amortisation
Non-Cash Items	30.6	973	294	1,813	102
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-395	-417	-136	111	116
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	250	93.4	-110	-165	99.2
Capital Expenditures	-667	-1,142	-857	-302	-238
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	62.1	-196	-1.51	29.7	75.9
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-605	-1,338	-858	-272	-162
Financing Cash Flow Items	744	-42.2	-10.8	-48.2	-60.8
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	1,139	788	980	362	-26.2
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	784	-456	9.53	-73.1	-88.9